US2020360516A1PendingUtilityA1

Trace elements

Assignee: WARBURTON TECHNOLOGY LTDPriority: Apr 29, 2004Filed: Aug 3, 2020Published: Nov 19, 2020
Est. expiryApr 29, 2024(expired)· nominal 20-yr term from priority
A61K 33/24A61K 33/00A61K 31/28A61K 33/26A61K 33/04A61K 45/06Y10S424/06A61K 33/34A61K 33/32A61K 33/30A61P 7/08Y10S514/836A61P 3/02
66
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

A trace element solution comprises selenium, zinc, manganese and copper at a concentration of at least 60 mg/ml. The solution may further comprise at least one compound selected from the group comprising iodine, potassium iodide, sodium iodide, zinc oxide, manganese sulphate, sodium selenite, copper carbonate, sodium carbonate, anhydrous disodium EDTA and sodium hydroxide.

Claims

exact text as granted — not AI-modified
What is claimed: 
     
         1 . An injectable trace element solution, said solution comprising:
 (a) selenium;   (b) zinc;   (c) manganese; and   (d) copper,   wherein a total concentration of selenium, zinc, manganese and copper in the solution is at least 60 mg/ml.   
     
     
         2 . The solution of  claim 1 , wherein the concentration of selenium in the to solution is 5 to 10 mg/ml. 
     
     
         3 . The solution of  claim 1 , wherein the concentration of zinc in the solution is 35 to 50 mg/ml. 
     
     
         4 . The solution of  claim 1 , further comprising at least one of iron and chromium. 
     
     
         5 . The solution of  claim 1 , further comprising at least one compound selected from the group consisting of iodine, potassium iodide, sodium iodide, zinc oxide, manganese sulphate, sodium selenite, copper carbonate, sodium carbonate, anhydrous disodium EDTA and sodium hydroxide. 
     
     
         6 . The solution of  claim 5 , wherein at least one of the metals is provided in the form of an EDTA complex. 
     
     
         7 . The solution of  claim 6 , wherein the EDTA complex is produced from at least one compound selected from the group consisting of sodium EDTA and potassium EDTA. 
     
     
         8 . The solution of  claim 1 , further comprising chlorocresol as preservative. 
     
     
         9 . The solution of  claim 1 , further comprising 5-10 mg/ml chromium. 
     
     
         10 . The solution of  claim 1 , wherein the iron in solution is 10-20 mg/ml. 
     
     
         11 . The solution of  claim 1 , further comprising 20-400 mg/ml iodine. 
     
     
         12 . The solution of  claim 1 , wherein the selenium is present in an amount of 5 mg/ml. 
     
     
         13 . The solution of  claim 1 , further comprising 5-10 mg/ml chromium.

Join the waitlist — get patent alerts

Track US2020360516A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.